163 related articles for article (PubMed ID: 24715245)
1. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.
Wichmann H; Güttler A; Bache M; Taubert H; Vetter M; Würl P; Holzhausen HJ; Eckert AW; Kappler M; Vordermark D
Strahlenther Onkol; 2014 Oct; 190(10):912-8. PubMed ID: 24715245
[TBL] [Abstract][Full Text] [Related]
2. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
3. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
5. Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
Bache M; Kappler M; Wichmann H; Rot S; Hahnel A; Greither T; Said HM; Kotzsch M; Würl P; Taubert H; Vordermark D
BMC Cancer; 2010 Apr; 10():132. PubMed ID: 20377868
[TBL] [Abstract][Full Text] [Related]
6. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
[TBL] [Abstract][Full Text] [Related]
7. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
9. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
[TBL] [Abstract][Full Text] [Related]
10. Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Posch F; Partl R; Döller C; Riedl JM; Smolle M; Leitner L; Bergovec M; Liegl-Atzwanger B; Stotz M; Bezan A; Gerger A; Pichler M; Kapp KS; Stöger H; Leithner A; Szkandera J
Ann Surg Oncol; 2018 Mar; 25(3):776-783. PubMed ID: 28895087
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas.
Takeda C; Takagi Y; Shiomi T; Nosaka K; Yamashita H; Osaki M; Endo K; Minamizaki T; Teshima R; Nagashima H; Umekita Y
Diagn Pathol; 2014 Oct; 9():205. PubMed ID: 25358722
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
17. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas.
Alamanda VK; Song Y; Shinohara E; Schwartz HS; Holt GE
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):633-40. PubMed ID: 24821569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
